Our innovative target-based technologies combine biology and
chemistry to enable efficient discovery of new compounds that
may serve as potential treatments for cancer, diabetes and
other diseases. Our chemistry-based approach is to modify
existing compounds to discover new drug candidates. More
specifically, we use database searches to identify
pharmacophore groups to design new drug candidates.
 | CANCER | |
| DIABETES | |
SONITU Pharmaceuticals is a biopharmaceutical company
utilizing innovative target-based approach to design and
discover novel drug candidates that can be developed as novel
treatments for cancer and diabetes.
.
utilizing innovative target-based approach to design and
discover novel drug candidates that can be developed as novel
treatments for cancer and diabetes.
.
Our business strategy is to discover proprietary drug candidates
and develop them to obtain pre-clinical data for proof-of-concept.
For further clinical development of the selected compounds, we
will seek business relationships with other pharmaceutical
companies
and develop them to obtain pre-clinical data for proof-of-concept.
For further clinical development of the selected compounds, we
will seek business relationships with other pharmaceutical
companies
| SONITU PHARMACEUTICALS |
 |
 |